Tiffany, Kors to Re...
Health Care: Drugs
Horizon Pharma Inc (HZNP: NASDAQ)
$2.40 0.01 | 0.42%
05/24/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 2.40 |
| 52 Week High | 8.72 |
| 52 Week Low | 1.97 |
| Avg. Daily Vol. (Mil) | 0.50 |
| Beta (3 year) | 0.00 |
| Share Related Items | |
| Mkt Cap (Mil) | 150.71 |
| Shares Out (Mil) | 62.80 |
| Float (Mil) | 44.71 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.30 |
| Current Ratio | 2.60 |
| LT Debt/ Equity | 0.41 |
| Total Debt / Equity | 0.60 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 4.84 |
| Price/Book | 1.79 |
| Price/Cash Flow | -1.20 |
| Per Share Data | |
| Earnings | -1.74 |
| Sales | 0.50 |
| Book Value | 1.34 |
| Cash Flow | -2.01 |
| Business Summary | |
|---|---|
| Horizon Pharma, Inc is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. | |
| General Information | |
| 1033 Skokie Boulevard
Suite 355 Northbrook, IL 60062 |
|
| www.horizonpharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 249 | |
| CEO: Mr. Timothy P. Walbert | |
| Short Interest | |
| Current Month (Mil) | 4.63 |
| Previous Month (Mil) | 4.79 |
| Short Interest Ratio (Days) | 11.90 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -78.20 |
| Return on Investments | -112.00 |
| Profitability | |
| Gross Margin | 72.80 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with HZNP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorDrugs Facing FDA Approval i...
- Usersuziltd
- ContributorBreakout Stocks Of The Week...
- Contributor4 Drug Stocks Facing FDA Ap...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
Latest HZNP Headlines from TheStreet
- 3 Stocks Under $10 Making Big Moves 03.15.13 | 07:03 am
- January Effect Stock Picks Here Are 7 Possible Winners For 2013 12.28.12 | 03:12 pm
- Shorting Alexza Pharma On FDA's Adasuve Approval 12.19.12 | 07:12 am
- 11 Stocks With Significant Institutional And Insider Buying 12.18.12 | 06:12 pm
- 10 Stocks With Bullish Institutional And Insider Buying Activities 12.04.12 | 04:12 pm
- 5 Stocks Insiders Love Right Now 10.03.12 | 01:10 pm
- Horizon Pharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.10.12 | 02:08 pm
- Biotech Stock Mailbag: Amarin, Sarepta 07.27.12 | 06:07 am
- Horizon Pharma: Rayos FDA Approval Thursday Seems Likely 07.25.12 | 10:07 am
- 28 Drugs Facing FDA Approval in 2012-2013 07.24.12 | 07:07 am
Press Releases for HZNP
- Horizon Pharma Announces Completion Of Sales Force Expansion - PR Newswire 10.01.12 | 07:10 am
- Horizon Pharma Announces Receipt Of Two Additional U.S. Patent Allowances For DUEXIS® - PR Newswire 09.28.12 | 07:09 am
- Horizon Pharma Announces FDA Approval Of RAYOS® (prednisone) Delayed-Release Tablets For Rheumatoid Arthritis And Multiple Additional Indications - PR Newswire 07.26.12 | 04:07 pm
- The Grünenthal Group Enters Into Exclusive Agreement With Horizon Pharma For Commercialization Of DUEXIS® In Latin America - PR Newswire 06.19.12 | 08:06 am
- Horizon Pharma Enters Into Exclusive Agreement With Grunenthal For Commercialization Of DUEXIS® In Latin America - PR Newswire 06.19.12 | 07:06 am
- Horizon Pharma And Mallinckrodt, The Pharmaceuticals Business Of Covidien, Enter Into Co-Promotion Agreement For DUEXIS® In The United States - PR Newswire 06.18.12 | 06:06 am
- Horizon Pharma Announces Issuance Of U.S. Patent Covering RAYOS (delayed-release Prednisone) - PR Newswire 05.29.12 | 07:05 am
Partner Headlines for HZNP
- Pre-Market Earnings Report for March 18, 2013 : KIOR, IMOS, NMRX, TA, HWCC, INSM, AMRC, PTX, STRL, HZNP, UTSI, DEXO - NASDAQ 03.15.13 | 08:03 pm
- The January Effect And 3 Biopharma Stocks - Seeking Alpha 11.09.12 | 09:11 am
- From Earlier: Horizon Pharma Announces US Patent for Rayos Tablet - Benzinga 10.15.12 | 09:10 am
- Huge Insider Buy Makes This $3.50 Biopharma Stock An Intriguing Speculative Play - Seeking Alpha 10.07.12 | 08:10 am
- Morning Market Losers - Benzinga 09.20.12 | 01:09 pm
- A Pullback Would Be Healthy For Repros Therapeutics - Seeking Alpha 09.20.12 | 09:09 am
- 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year - Seeking Alpha 08.28.12 | 09:08 am
- 6 Healthcare Stocks With Pending August Catalysts - Seeking Alpha 08.01.12 | 09:08 am
- 4 Hot Healthcare Stocks Making Mid-Week Noise - Seeking Alpha 07.25.12 | 09:07 am
- Earnings Preview: Covidien - Analyst Blog - Zacks 07.23.12 | 10:07 am
